v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (13,192) $ (10,340)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,191 1,208
Operating lease right-of-use assets 105 112
Depreciation and amortization 34 37
Accretion of available-for-sale marketable securities, net (431) (395)
Changes in operating assets and liabilities:    
Accrued expenses and other liabilities (1,075) (1,501)
Accounts payable (1,483) (1,993)
Prepaid expenses and other current assets (2,838) (605)
Net cash used in operating activities (16,689) (13,477)
Investing activities:    
Proceeds from maturities of available-for-sale marketable securities 25,552 17,595
Purchases of available-for-sale marketable securities (8,485) (27,546)
Purchases of property, equipment and leasehold improvements (102)  
Net cash provided by (used in) investing activities 16,965 (9,951)
Financing activities:    
Proceeds from exercises of stock options 222 718
Proceeds from exercises of warrants   8,220
Payments of offering costs   (222)
Payments of finance lease   (11)
Net cash provided by financing activities 222 8,705
Net increase (decrease) in cash and cash equivalents 498 (14,723)
Cash and cash equivalents at beginning of period 18,914 34,097
Cash and cash equivalents at end of period $ 19,412 $ 19,374